Dolby Laboratories (DLB) Stock

The study showed significant positive effects on behavior, function, cognition, and movement in patients with mild to moderate DLB.

Dolby Laboratories (DLB) reported quarterly earnings of $1.14 per share, which is higher than the Zacks Consensus Estimate of $1.07 per share. This is an increase compared to earnings of $1.01 per share from the same period last year.

SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) has released its financial results for the first quarter of fiscal 2025. Kevin Yeaman, the President and CEO of Dolby Laboratories, stated, "We have made a strong beginning for FY25."

DLB's financial results for the first quarter are expected to have improved due to the popularity of Dolby Atmos and Dolby Vision, even though device sales have been weak.

Stocks such as DLB, CCL, NFLX, and AOUT are likely to gain from the positive outlook on interest rate reductions.

Dolby Laboratories (DLB) may not have the right mix of the two important factors needed for a potential earnings surprise in its next report. Be ready for the main expectations.

No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.

This Analyst Blog features companies like Carnival Corporation, The Walt Disney Company, Dolby Laboratories, Royal Caribbean Cruises, and Ralph Lauren.

Investing in advanced and innovative solutions is expected to help companies in the Zacks Audio Video Production industry, such as SONY, DLB, and GPRO, even with careful spending habits.